Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Articles, Neurobiology of Disease

Additive Gene–Environment Effects on Hippocampal Structure in Healthy Humans

Ulrich Rabl, Bernhard M. Meyer, Kersten Diers, Lucie Bartova, Andreas Berger, Dominik Mandorfer, Ana Popovic, Christian Scharinger, Julia Huemer, Klaudius Kalcher, Gerald Pail, Helmuth Haslacher, Thomas Perkmann, Christian Windischberger, Burkhard Brocke, Harald H. Sitte, Daniela D. Pollak, Jean-Claude Dreher, Siegfried Kasper, Nicole Praschak-Rieder, Ewald Moser, Harald Esterbauer and Lukas Pezawas
Journal of Neuroscience 23 July 2014, 34 (30) 9917-9926; DOI: https://doi.org/10.1523/JNEUROSCI.3113-13.2014
Ulrich Rabl
1Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernhard M. Meyer
1Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kersten Diers
2Department of Psychology, Dresden University of Technology, 01069 Dresden, Germany,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucie Bartova
1Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Berger
1Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominik Mandorfer
1Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Popovic
1Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Scharinger
1Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Huemer
3Department of Child and Adolescent Psychiatry,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klaudius Kalcher
4MR Center of Excellence,
5Center for Medical Physics and Biomedical Engineering,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerald Pail
1Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helmuth Haslacher
6Department of Laboratory Medicine,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Helmuth Haslacher
Thomas Perkmann
6Department of Laboratory Medicine,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Windischberger
4MR Center of Excellence,
5Center for Medical Physics and Biomedical Engineering,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christian Windischberger
Burkhard Brocke
2Department of Psychology, Dresden University of Technology, 01069 Dresden, Germany,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harald H. Sitte
7Center of Physiology and Pharmacology, Institute of Pharmacology, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Harald H. Sitte
Daniela D. Pollak
8Department of Neurophysiology and Neuropharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, A-1090 Vienna, Austria,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Claude Dreher
9Neuroeconomics Laboratory: Reward and Decision-Making, Centre de Neurosciences Cognitives, Centre National de la Recherche Scientifique/Unité Mixte de Recherche 5229, 69500 Bron, France, and
10Université Claude Bernard Lyon 1, 69100 Villeurbanne, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jean-Claude Dreher
Siegfried Kasper
1Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole Praschak-Rieder
1Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ewald Moser
4MR Center of Excellence,
5Center for Medical Physics and Biomedical Engineering,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harald Esterbauer
6Department of Laboratory Medicine,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lukas Pezawas
1Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lukas Pezawas
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Hippocampal volume loss has been related to chronic stress as well as genetic factors. Although genetic and environmental variables affecting hippocampal volume have extensively been studied and related to mental illness, limited evidence is available with respect to G × E interactions on hippocampal volume. The present MRI study investigated interaction effects on hippocampal volume between three well-studied functional genetic variants (COMT Val158Met, BDNF Val66Met, 5-HTTLPR) associated with hippocampal volume and a measure of environmental adversity (life events questionnaire) in a large sample of healthy humans (n = 153). All three variants showed significant interactions with environmental adversity with respect to hippocampal volume. Observed effects were additive by nature and driven by both recent as well as early life events. A consecutive analysis of hippocampal subfields revealed a spatially distinct profile for each genetic variant suggesting a specific role of 5-HTTLPR for the subiculum, BDNF Val66Met for CA4/dentate gyrus, and COMT Val158Met for CA2/3 volume changes. The present study underscores the importance of G × E interactions as determinants of hippocampal volume, which is crucial for the neurobiological understanding of stress-related conditions, such as mood disorders or post-traumatic stress disorder (PTSD).

  • COMT
  • SLC6A4
  • BDNF
  • MRI
  • hippocampus
  • stress

Introduction

Hippocampal neuroplasticity is critical for cognitive plasticity, novelty learning, and individuality in humans and animals (Garthe et al., 2009; Sahay et al., 2011; Freund et al., 2013; Spalding et al., 2013) and further moderates the adaptation to environmental changes, a process that is intimately linked to hypothalamus-pituitary-adrenal (HPA) axis function (Snyder et al., 2011). Apart from providing negative feedback to the HPA axis, the hippocampus is also a major target of cortisol, which is highlighted by cortisol-mediated hippocampal volume loss after chronic stress exposure (Sapolsky et al., 1990; McEwen, 2001; Brown et al., 2004). The clinical importance of hippocampal volume loss has been shown by numerous studies investigating stress-related and heritable neuropsychiatric disorders, such as major depressive disorder (MDD), post-traumatic stress disorder (PTSD), and schizophrenia (Nelson et al., 1998; MacQueen and Frodl, 2011; Kühn and Gallinat, 2013). In addition to environmental adversity (Gianaros et al., 2007; Dannlowski et al., 2012), genetic variation is known to affect hippocampal volume (MacQueen and Frodl, 2011). Interestingly, several genetic variants known for their direct effects on hippocampal volume have been related to stress susceptibility suggesting the possibility of gene–environment (G × E) interactions at the neural level (Caspi and Moffitt, 2006). This applies specifically to three genetic variants impacting serotonin, dopamine, and neurotrophin signaling. 5-HTTLPR, a functional promoter polymorphism of the serotonin transporter gene (SLC6A4), modulates the relationship between environmental adversity and depression risk (Caspi et al., 2003) resulting in increased cortisol signaling and amygdala response to stressors in S carriers (Hariri et al., 2002; Canli et al., 2006; Miller et al., 2013). Similarly, BDNF Val66Met, a single nucleotide polymorphism (SNP) located in the brain-derived neurotrophic factor gene (BDNF), has been associated with stress susceptibility (Gatt et al., 2009; Alexander et al., 2010). Further, COMT Val158Met, a functional SNP located in the catechol-O-methyltransferase gene (COMT), has been implicated in HPA axis hyper-reactivity (Armbruster et al., 2012), altered μ-opioid neurotransmitter responses to pain stressors (Zubieta et al., 2003), and increased limbic reactivity (Smolka et al., 2005). In line with their effects on the stress system and brain function, these variants have repeatedly been shown to directly affect hippocampal volume (Pezawas et al., 2004; Frodl et al., 2008; Honea et al., 2009), although others failed to show these effects (Dutt et al., 2009; Cole et al., 2011; Molendijk et al., 2012). Such inconsistency is not surprising given the complex interplay between various genes and environmental factors that determine hippocampal volume. The nonconsideration of G × E interactions might be the leading reason for such inconclusive results, especially given that the functional role of the mentioned variants in stress reactivity provides a strong argument for their candidacy in G × E research (Moffitt et al., 2005).

To elucidate potential G × E interactions of these variants on the volume of the hippocampus and its subfields, which considerably vary with respect to their stress sensitivity (McEwen, 2001; Teicher et al., 2012), we conducted an MRI study in a large sample of healthy individuals.

Materials and Methods

Subjects.

Healthy subjects were recruited by online advertisements, announcements on bulletin boards, and word of mouth at two study sites (Division of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria, and Department of Psychology, Dresden University of Technology, Dresden, Germany). All assessments were performed following the same standard procedure, which has been approved by the local ethics committee according to the Declaration of Helsinki (2008): Only right-handed native German speakers of European ancestry aged between 18 and 45 years were invited to participate in this study. Before inclusion, study protocol procedures have been fully explained to study participants before obtaining written informed consent. All participants were further financially compensated for their expenditure of time. At the screening day, subjects underwent a thorough physical examination, including electrocardiography, blood pressure measurement, and routine laboratory testing. Moreover, subjects underwent the Structured Clinical Interview for DSM-IV Axis I disorders (APA, 2000) to ascertain absence of any past or present psychiatric diagnosis except nicotine dependence. The final sample consisted of 153 subjects (21 from the Dresden study site) after exclusion of three subjects due to segmentation failure (female, age 31 years, COMT Val158Met: Met/Met, 5-HTTLPR: SA/LA, BDNF Val66Met: Val/Val; female, age 19 years, COMT Val158Met: Val/Met, 5-HTTLPR: LA/LA,BDNF Val66Met: Val/Met; male, age 27 years, COMT Val158Met: Val/Met, 5-HTTLPR: LA/LA, BDNF Val66Met: Val/Val) following visual quality control of the segmented structural images.

Behavioral measures.

All subjects were asked to complete the life events questionnaire (LEQ), which is a short form of the life history calendar, a data collection method for obtaining reliable retrospective data about life events (LEs) and activities (Caspi et al., 1996; Canli et al., 2006). This self-report questionnaire comprises 28 stressful LEs (Fig. 1). Subjects were asked to indicate whether, when, and how often they had experienced a particular event. The sum of all LEs resulted in the total LEQ score. To test for effects of temperament, the German version of the Temperament and Character Inventory (Version 9) was applied (Cloninger et al., 1993).

Genotyping.

DNA extraction and genotyping were performed at the Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria. DNA was isolated from EDTA blood samples using the Magna Pure LC DNA Isolation Kit (Roche). A tetra-primer amplification refractory mutation system-PCR (ARMS-PCR) was used for COMT Val158Met (rs4680) genotyping following a previously published protocol (Ruiz-Sanz et al., 2007). All subjects were further genotyped for the SLC6A4 promoter variant (5-HTTLPR), including rs25531 following a previously published protocol (Wendland et al., 2006). Genotyping resulted in 24 SA/SA, 56 SA/LA, 12 SA/LG, 1 SG/LA, 12 LA/LG, and 48 LA/LA carriers. Because the LG allele equals the S allele with regard to 5-HTT expression, the LG allele was grouped together with the S allele (Hu et al., 2006) and is for simplicity referred to as S allele in the course of the manuscript. BDNF Val66Met (rs6265) genotyping was performed using a TaqMan (Applied Biosystems) 5′-nuclease assay. Sequence detection was accomplished in a 384-well format on an ABI 7900HT RT-PCR thermocycler (Applied Biosystems) applying 10 ng genomic DNA in a total volume of 10 μl consisting of 5 μl TaqMan Genotyping Mastermix (Applied Biosystems) and 0.25 μl of a 20× TaqMan Genotyping assay (Assay ID C_11592758_10, Applied Biosystems) containing sequence-specific primers and probes. PCR was performed under the following conditions: initial denaturation step (10 min, 95°C), followed by 40 cycles of DNA denaturation (15 s, 95°C) and oligonucleotide annealing/strand elongation (60 s, 60°C). Evaluation of data was realized using SDS 2.3 sequence detection software (Applied Biosytems). BDNF Val66Met genotyping resulted in 5 Met/Met, 52 Val/Met, and 96 Val/Val carriers. There was no indication for deviation from Hardy-Weinberg equilibrium for COMT Val158Met (p = 0.19), BDNF Val66Met (p = 0.64), 5-HTTLPR (p = 0.50), and rs25531 (p = 0.39).

MRI: acquisition.

3 Tesla (3T) TIM Trio scanners equipped with Siemens 12-channel head coils (Siemens Medical Solutions) were used for structural MRI measurements at both study sites using the same scan protocol and quality control procedures. Head movements were restricted using foam pillows. Structural images were acquired using a 3D magnetization-prepared rapid acquisition with a gradient echo sequence (3D MPRAGE, TR/TE = 2300/4.21 ms, flip angle = 9°, inversion time = 900 ms, and voxel size = 1 × 1 × 1.1 mm). Preprocessing: Anatomical MRI preprocessing was performed on a Linux computer (Red Hat Enterprise Linux 5, x86_64 architecture) using FreeSurfer version 5.1.0 (http://surfer.nmr.mgh.harvard.edu/), a set of automatic tools for morphological operations that require little or no human interventions. Preprocessing included registration to Talairach space, intensity normalization, removal of nonbrain tissue, and segmentation. Hippocampi were delineated by a subcortical segmentation procedure that assigns to each voxel one of 37 anatomical labels based on voxel intensity, intensity of neighboring voxels, and atlas-based prior probabilities (Fischl et al., 2002). Hippocampal subfields were defined by the use of Bayesian inference within a statistical model of image formation around the hippocampus (Van Leemput et al., 2009). Hippocampal volumes as well as subfields were corrected for total intracranial volume using the residual method (Sanfilipo et al., 2004).

Statistics.

To test for interaction effects between genotype and LEs, linear regression models were used with total hippocampal or hippocampal subfield volume as dependent variables and the interactions between COMT Val158Met, BDNF Val66Met, and 5-HTTLPR genotypes and LEs as independent variables. Age, gender, and study site were included as covariates. The following regressors for genotype variables were used: For COMT Val158Met, a linear allele-dose model was assumed by regressing the number of Met alleles (0, 1, 2) given the overwhelming evidence for dosing effects of COMT Val158Met (Smolka et al., 2005; Drabant et al., 2006; Domschke et al., 2012). 5-HTTLPR genotypes were collapsed into risk allele carriers (S allele carriers) and LA homozygotes in analogy to previous imaging genetics studies and coded as 0 (LA homozygotes) and 1 (S carriers) (Canli et al., 2006). Similarly, BDNF Val66Met genotypes were grouped into Met carriers (coded as 0) and Val homozygotes (coded as 1) as in previous studies (Kambeitz et al., 2012). A separate regression model, including the same regressors without the interaction terms, was used to assess potential main effects of genotype and LEs. Where applicable, the resulting p values were corrected for multiple comparisons using the Bonferroni–Holm method (Holm, 1979). Likelihood-ratio tests and Akaike information criterion were used for comparison of nested and non-nested models, respectively. To assess the variance explained by the interaction terms for each hippocampal subfield, we used the lmg metric (R2 partitioned by averaging over orders, provided in R package “relaimpo,” function “calc.relimp”) to break down R2 into shares from the individual regressors in analogy to a previous study (Teicher et al., 2012). All statistical analyses were conducted in R (version 2.15.2; http://cran.r-project.org/).

Results

Demographics

The sample consisted of 153 subjects (81 females, 72 males) with an average age of 23.79 ± 3.03 years (range: 18–43 years; percentiles: 25th: 22 years; 50th: 23 years; 75th: 25 years). Subjects were generally well educated as reflected by the percentage (98%) receiving 12 or more years of schooling. The distributions of 5-HTTLPR, BDNF Val66Met, and COMT Val158Met did not significantly differ between each other (all p > 0.05; Tables 1, 2, and 3). As shown in Tables 1, 2, and 3, genotype groups did not significantly vary with respect to age, gender, smoking status, or study site. Subjects reported on average 4.77 ± 3.14 LEs (range: 0–15 events; percentiles: 25th: 2 events; 50th: 5 events; 75th: 6 events), which occurred on average 5.75 ± 5.07 years before the MRI scan (range: 0–32 years; percentiles: 25th: 2 years; 50th: 4 years; 75th: 9 years). The type and timeline of all LEs in the whole sample are depicted in Figure 1. The number of LEs was significantly correlated with age (ρ = 0.18, p = 0.02). To obtain a measure of stressor intensity and to avoid correlated regressors, we corrected the number of LEs by age, resulting in an average of 0.20 ± 0.13 LEs per year. There was no significant difference with regard to LE between COMT Val158Met, BDNF Val66Met, and 5-HTTLPR groups (all p > 0.05; Tables 1, 2, and 3).

View this table:
  • View inline
  • View popup
Table 1.

Distributions, sample sizes, means, and SDs according to COMT Val158Met genotypesa

View this table:
  • View inline
  • View popup
Table 2.

Distributions, sample sizes, means, and SDs according to BDNF Val66Met genotypesa

View this table:
  • View inline
  • View popup
Table 3.

Distributions, sample sizes, means, and SDs according to 5-HTTLPR genotypesa

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Type and timeline of LEs as reported by the sample (n = 153). LEs are sorted by number of occurrence.

G × E effects on hippocampal volume

There were no significant main effects of COMT Val158Met, BDNF Val66Met, 5-HTTLPR, or LE on total hippocampal volume (Table 4; Fig. 2). However, each genotype exhibited a significant and independent interaction effect with LE indicating increased negative impact of LE on hippocampal volume in COMT Met homozygotes, BDNF Val homozygotes, or 5-HTTLPR S allele carriers (Table 4; Fig. 2). There was no evidence for statistical epistasis with regard to these interaction effects (LE × Val158Met × 5-HTTLPR: b = −0.13, SE = 0.17, t(140) = −0.76, p = 0.45; LE × Val158Met × Val66Met: b = 0.12, SE = 0.16, t(140) = 0.75, p = 0.45; LE × Val66Met × 5-HTTLPR: b = −0.19, SE = 0.36, t(140) = −0.53, p = 0.60). Given the independence of G × E interaction effects in previous analyses, we performed a post hoc analysis of the combined genetic effect on hippocampal volume. Based on above-mentioned results, we constructed a cumulative risk score (CRS) by summing up genetic risk factors (number of COMT Met alleles, 5-HTTLPR S allele, and BDNF Val/Val genotype) for each individual. CRS was highly predictive for hippocampal volume in interaction with LE (b = −0.41, SE = 0.08, t(146) = −4.99, p < 0.00001; Fig. 3A). Interestingly, this interaction exhibited a gradual effect on hippocampal volume ranging from volume increases to decreases dependent on the load of genetic risk (Fig. 3A). The more parsimonious CRS model explained nearly as much variance as the full model (full model: R2 = 0.19, Table 4; additive model: R2 = 0.18, F(6,146), p < 0.0001) and reduced the Akaike information criterion by 5.96 indicating improved model performance. Moreover, this additive effect was even detectable when analyzing sites separately (Vienna: n = 132, b = −0.42, SE = 0.10, t(126) = −4.10, p < 0.0001; Dresden: n = 21, b = −0.39, SE = 0.15, t(15) = −2.59, p = 0.021). The model fit, however, varied substantially: in the genetically more consistently defined groups, LE explained between 38% and 42% of hippocampal volume variance, notably in opposite directions (CRS = 1: n = 19, b = 0.69, s2 = 42%; CRS = 4: n = 15, b = −0.68, s2 = 38%), whereas only 1% and 5% variance was observed in the intermediate groups. We further performed several post hoc analyses to exclude effects of potential confounding variables on these G × E interaction effects (detailed statistics available upon request). There were no significant main or interaction effects of smoking status (n = 152, all p > 0.6), gender (all p > 0.5), harm avoidance, or novelty seeking (all p > 0.05). Additionally, including all possible covariate × environment and covariate × genotype interactions (similar to model 4 in Keller, 2014) revealed no significant differences to the parsimonious models (full model: F(12,130), p = 0.79, additive model: F(6,140), p = 0.64) and no change in significance or direction of effects. To explore whether these G × E interaction effects were driven by recent or early LEs, we conducted separate analyses restricted to specific developmental periods. Participants reported significantly less LEs during childhood (first 15 years of life) than during the last 5 years before the MRI scan (1.03 ± 1.12 vs 2.52 ± 2.07, t(152) = −8.29, p < 0.001). A restriction to the last 5 years showed a similar, but less significant, pattern compared with the full set of LEs (COMT: b = −0.23, SE = 0.09, t(142) = −2.54, p = 0.01, BDNF: b = −0.39, SE = 0.18, t(142) = −2.11, p = 0.04, SLC6A4: b = −0.32, SE = 0.17, t(142) = −1.89, p = 0.06, additive model: b = −0.33, SE = 0.09, t(142) = −3.76, p < 0.001). Similarly, a restriction to childhood revealed an almost identical, but also less significant, pattern (COMT: b = −0.17, SE = 0.08, t(142) = −2.19, p = 0.03, BDNF: b = −0.26, SE = 0.17, t(142) = −1.58, p = 0.12, SLC6A4: b = −0.28, SE = 0.17, t(142) = −1.63, p = 0.11, additive model: b = −0.25, SE = 0.07, t(142) = −3.34, p = 0.001). Nevertheless, both models explained major parts of variance in total hippocampal volume, but considerably less than the full model (last 5 years: R2 = 0.13, F(10,142) = 2.18, p = 0.023; childhood: R2 = 0.12, F(10,142) = 1.92, p = 0.047; LE: R2 = 0.19, F(10,142) = 3.40, p < 0.001).

View this table:
  • View inline
  • View popup
Table 4.

Gene × LE interaction effects on hippocampal volumea

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Main effects and gene × LE interaction effects of genetic variation in COMT, SLC6A4, and BDNF on hippocampal volume. Left panel side: Main effects of COMT Val158Met (A), 5-HTTLPR (B), and BDNF Val66Met (C) on hippocampal volume for 153 subjects (n per genotype group is shown in Tables 1, 2, and 3). Hippocampal volumes are corrected for intracranial volume as well as the remaining variables according to the main effects model described in Table 4. The gray box represents the 95% confidence interval. Right panel side: Interaction effects between LEs/year and COMT Val158Met (A), 5-HTTLPR (B), and BDNF Val66Met (C) on hippocampal volume for 153 subjects (n per genotype group is shown in Tables 1, 2, and 3). Hippocampal volumes are corrected for intracranial volume as well as the remaining variables according to the interaction effects model described in Table 4.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

A, Interaction effect between additive genetic risk and LEs/year on hippocampal volume for 153 subjects. Scatter plots between LEs/year and hippocampal volume are shown separately for the number of genetic risk factors (COMT Met alleles, 5-HTTLPR S carrier, BDNF Val/Val carrier). The individual genotype groups are shown above. COMT Val158Met: Val/Val (VV), Val/Met (VM), Met/Met (MM); 5-HTTLPR: LA homozygotes (L), S carrier (S); BDNF Val66Met: Met carrier (M), Val homozygotes (V). B, Hippocampal subfield segmentation of a randomly drawn subject from the Dresden study site. The subfields are color-matched to Figure 3D. C, Hippocampal subfield segmentation of a randomly drawn subject from the Vienna study site. The subfields are color-matched to Figure 3D. D, Percent variance (s2) of hippocampal subfield volumes explained by the interaction effects between LEs/year and COMT Val158Met, BDNF Val66Met, 5-HTTLPR, and the additive risk score for 153 subjects. Bonferroni-Holm-corrected significance of the interaction effect is indicated as follows: +Corrected p < 0.1. *Corrected p < 0.05. **Corrected p < 0.01. ***Corrected p < 0.001. COMT, COMT Val158Met; BDNF, BDNF Val66Met; SLC6A4, 5-HTTLPR; LE, LEs/year.

G × E effects on hippocampal subfield volumes

To study observed G × E interaction effects in specific hippocampal substructures, we applied a novel method for hippocampal subfield segmentation (Fig. 3B,C) allowing for the distinction between presubiculum, subiculum, fimbria, CA1, CA2/3, and CA4/dentate gyrus (Van Leemput et al., 2009). Similar to total hippocampal volume, no main effects of genotype or LE on any of these subfields were present (all p > 0.05). In contrast, G × E interaction analyses revealed spatially distinct effects for single genetic variants that exhibited the same direction as being found for total hippocampal volume (Table 5; Fig. 3D). Interestingly, all genetic variants showed no significant effects at the presubiculum or fimbria, whereas most effects were present in subiculum and Ammon's horn (Table 5; Fig. 3D). In contrast to single G × E effects, the additive model exhibited effects across almost all subfields. Whereas only the right fimbria fell short of significance before multiple comparison correction, nine of the 12 subfields survived Bonferroni-Holm correction, namely, CA1, CA2/3, CA4/dentate gyrus, and subiculum on both hemispheres as well as the left presubiculum. Within these subfields, the interaction effect between LE and CRS explained between 4% and 12% of variance in volume with maximal effects present in right hemispheric regions implicated in neurogenesis and neuroplasticity, such as CA2/3 (12% explained variance) and CA4/dentate gyrus (11% explained variance, Table 5; Fig. 3D).

View this table:
  • View inline
  • View popup
Table 5.

Gene × LE interaction effects on hippocampal subfieldsa

Discussion

This study provides evidence for the presence of interaction effects between stressful LEs and three functional genetic variants on total hippocampal and hippocampal subfield volumes in healthy individuals in line with previous imaging, animal, and epidemiological evidence (McEwen, 2001; Caspi et al., 2003; Canli et al., 2006; Gianaros et al., 2007). These results highlight the need to model G × E interactions at the intermediate phenotype level to sufficiently map the intimate relationship between environmental and genetic variability (Caspi and Moffitt, 2006).

We observed that the impact of stressful LEs on hippocampal volume is significantly modulated by variation in COMT, BDNF, and SLC6A4 independent of gender, smoking, and temperament. Notably, these effects were driven by both recent and childhood events, suggesting that environmental effects on hippocampal volume occur throughout life and probably last for years (Teicher et al., 2012; Gray et al., 2013).

For COMT Val158Met, we observed a dose-dependent effect of the Met allele resulting in a gradual change from a positive to a negative correlation between LE and hippocampal volume in line with its previously described pleiotropic effects on brain function and behavior (Mier et al., 2010). Previous studies suggested that Met homozygosity strengthens prefrontal cognitive stability (Mier et al., 2010). However, this benefit comes with a trade-off of disadvantageous emotion-related information processing likely because of increased subcortical tonic and increased cortical phasic dopaminergic signaling (Bilder et al., 2004; Mier et al., 2010). Correspondingly, the Met allele has been associated with stress-related phenotypes, such as exaggerated limbic response to unpleasant stimuli (Smolka et al., 2005, 2007), HPA axis hyperreactivity (Armbruster et al., 2012), and increased pain sensitivity (Zubieta et al., 2003). This balance of costs and benefits suggests that each allele can be advantageous depending on the environmental context (“warrior vs worrier” model) in line with our data (Goldman et al., 2005). Interestingly, COMT Val158Met effects were most pronounced in CA1, CA2/3, CA4/dentate gyrus, and subiculum, which is in line with preclinical research suggesting disruptive effects of glucocorticoids and repeated stressors on neurogenesis or neuroplasticity in these hippocampal regions (Sousa et al., 2000; McEwen et al., 2012; MacDougall and Howland, 2013). The specific mechanisms of how dopamine affects hippocampal volume are still obscure but may involve alterations of the dopamine-modulated stress response that translate to changes of HPA axis function (Armbruster et al., 2012; Hernaus et al., 2013). Moreover, given the high hippocampal COMT expression, also direct effects on local dopamine signaling and hippocampal plasticity may be possible (Matsumoto et al., 2003; Lisman et al., 2011; Laatikainen et al., 2012).

G × E interactions on hippocampal volume were also present for BDNF Val66Met in this study. The Val allele, which drove hippocampal volume loss in our data, has shown to promote social defeat stress susceptibility in mouse models because of increased BDNF signaling within the reward circuitry (Krishnan et al., 2007). In humans, Val/Val individuals have been linked to increased neuroticism (Frustaci et al., 2008), diminished antidepressant response (Niitsu et al., 2013), and heightened stress vulnerability (Yu et al., 2012; Jiang et al., 2013). Interestingly, we found maximal effects of BDNF Val66Met in CA4/dentate gyrus, where BDNF loss has been associated with depressive behavior and attenuated antidepressant efficacy (Adachi et al., 2008; Taliaz et al., 2010). However, this region is also highly susceptible to stressor-induced glucocorticoid signaling (Karst and Joels, 2003). It is therefore possible that an exaggerated stress response in Val/Val individuals (because of increased BDNF signaling in the mesolimbic dopamine circuit) diminishes the positive effect of increased BDNF signaling in the hippocampus (Krishnan et al., 2007; Alexander et al., 2010).

Furthermore, hippocampal volume loss was mediated by the S allele of 5-HTTLPR in our analyses in line with previous reports and highlighting the specific role of this allele in stress susceptibility (Hariri et al., 2002; Caspi et al., 2003; Canli et al., 2006; Frodl et al., 2010). 5-HTTLPR has been extensively studied and is known to alter serotonergic neurotransmission as well as brain development (Gaspar et al., 2003; Fisher et al., 2012; Migliarini et al., 2013). Accordingly, the observed effects could be driven by both direct and indirect serotonergic effects, including 5-HTTLPR-mediated alterations of HPA axis activity or direct effects of serotonin on neuroplasticity (Martinowich and Lu, 2008; Klempin et al., 2013; Miller et al., 2013). In this study, 5-HTTLPR exerted maximal effects in the subiculum, which is the principal hippocampal relay for HPA axis control and exhibits neuroplastic changes in response to stress (MacDougall and Howland, 2013). Interestingly, the subiculum is also densely packed with 5-HT1A and 5-HT1B receptors, which are involved in the serotonergic antidepressant response (Boeijinga and Boddeke, 1996; Hall et al., 1997; Cai et al., 2013).

There was no evidence for gene–gene interactions in our data, which may be understandable given that these genes are involved in distinct molecular pathways (Hemani et al., 2014). Instead, most of the individual variance was captured by a simple additive model suggesting that the observed G × E effects on hippocampal volume accumulate similar to other stress-related endophenotypes (Smolka et al., 2007; Stone et al., 2013) or quantitative traits (Hill et al., 2008; Yang et al., 2010). Notably, this additive effect predominantly affected hippocampal subfields that have been reported to be specifically vulnerable to childhood maltreatment, glucocorticoids, or stress in general (Sousa et al., 2000; McEwen et al., 2012; Teicher et al., 2012; MacDougall and Howland, 2013).

Interestingly, subjects at low genetic risk exhibited effects that were diametrically opposite to subjects at high genetic risk in our study. Although mathematically obvious, the biological meaning of this finding is less intuitive. Even so, a significant body of evidence exists that implicates factors promoting well-being in hippocampal growth (Kempermann et al., 1997; Pollak et al., 2008; Erickson et al., 2011; Davidson and McEwen, 2012; Arnone et al., 2013). Moreover, resilience, coping behavior, predictable stress, and low-dose glucocorticoids have been reported to stimulate hippocampal neurogenesis and neuroplasticity (Jeanneteau et al., 2008; Lyons et al., 2010; Schloesser et al., 2010; Delgado y Palacios et al., 2011; Parihar et al., 2011; Chen et al., 2012). It is therefore tempting to speculate that more beneficial stress coping behavior in individuals at lower genetic risk may have led to positive associations in our data. However, it needs to be emphasized that this is highly speculative given the correlative nature of our data and unresolved questions with respect to stress-related hippocampal changes (Czéh and Lucassen, 2007; Petrik et al., 2012). Nonetheless, such diametrically opposite effects may explain the lack of a significant main effect of LEs in several large healthy samples, including this study (Dannlowski et al., 2012; Luby et al., 2012).

The present study is not without limitations. The investigated sample is healthy, highly educated, and fairly homogeneous with regard to age, thereby controlling for major confounders, which might have been advantageous for the detection of subtle effects (Uher and McGuffin, 2008). However, this limits, on the other hand, the generalizability of our results, which especially cannot be extrapolated to patients. Subjects participating in this study reported considerably more recent than early LEs, which may reflect both the difficulty of recalling childhood memories as well as the different landscape of childhood stress (Howe, 2013). The reported diminished significance for early LEs could therefore be attributed to difficulties in memory recall rather than to lower G × E effects on hippocampal volume per se. It would therefore be interesting to further assess these interactions with regard to early life stressors (Teicher et al., 2012). Furthermore, there are other genetic variants in genes, such as FKBP5, CRHR1, NR3C2, or KIBRA, that have been associated with stress vulnerability or hippocampal structure (Mandelli and Serretti, 2013). However, the study of a higher number of variants would unlikely have led to meaningful results given the expected small effects and the requirement for rigorous Type I error control. We therefore focused on three functional variants that have been related to hippocampal structure and, most importantly, stress reactivity by numerous studies providing strong a priori support for the investigated effects (Moffitt et al., 2005). Another limitation is the lack of functional measures of stress responsiveness in our sample, which would have allowed for assessing the potential mediatory effect of HPA axis reactivity. However, the impact of these genotypes on stress reactivity has repeatedly been demonstrated before and was therefore beyond the scope of this study. Finally, pharmacological or behavioral stress tests offer the possibility of standardized stressors that are free of any recall bias but are not suited to study the long-term consequences of real life stressors as intended in our study (Pilger et al., 2014).

In conclusion, this study provides evidence of interaction effects between three well-studied functional genetic variants and environmental adversity on hippocampal anatomy, thereby resembling previous animal, molecular biology, genetic, and imaging work. These results highlight the importance of G × E interactions in imaging studies, which should facilitate a better understanding of the complex interplay between genes and the environment in future research.

Footnotes

  • This work was supported by the Special Research Project SFB-35 (F3514-B11 and F3506-B11) of the Austrian Science Fund, the Oesterreichische Nationalbank (OeNB 11903), and the Institute for the Study of Affective Neuroscience. U.R. was further supported by an award of the Theodor Körner Fonds. J.-C.D. was supported by the LABEX ANR-11-LABEX-0042 of Université de Lyon, within the program “Investissements d'Avenir” (ANR-11-IDEX-0007) operated by the French National Research Agency. We thank Kristin Anacker, Department of Psychology, Dresden University of Technology, Germany, for sharing expertise on the life events questionnaire; Pia Auersperg, Anastasia Gudakovskaja, Viktoria Köller, Elisabeth Kühtreiber, Franziska Mayr, Helge Oswald, Lisa Ott, Sophia Petschnak, Matthias Pilgerstorfer, Sebastian Ribar, and Marie Janina Schwidde for support of study participant recruitment and evaluation; Christian Kasess, Wolfgang Huf, and Roland Boubela for technical advice; and the anonymous reviewers for their suggestion to analyze effects of multiple genetic variants and other thoughtful comments.

  • The authors declare no competing financial interests.

  • Correspondence should be addressed to Dr. Lukas Pezawas, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. lukas.pezawas{at}meduniwien.ac.at

This article is freely available online through the J Neurosci Author Open Choice option.

References

  1. ↵
    1. Adachi M,
    2. Barrot M,
    3. Autry AE,
    4. Theobald D,
    5. Monteggia LM
    (2008) Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry 63:642–649, doi:10.1016/j.biopsych.2007.09.019, pmid:17981266.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Alexander N,
    2. Osinsky R,
    3. Schmitz A,
    4. Mueller E,
    5. Kuepper Y,
    6. Hennig J
    (2010) The BDNF Val66Met polymorphism affects HPA-axis reactivity to acute stress. Psychoneuroendocrinology 35:949–953, doi:10.1016/j.psyneuen.2009.12.008, pmid:20079575.
    OpenUrlCrossRefPubMed
    1. APA
    (2000) Diagnostic and statistical manual of mental disorders: DSM-IV-TR (American Psychiatric Association, Washington, DC).
  3. ↵
    1. Armbruster D,
    2. Mueller A,
    3. Strobel A,
    4. Lesch KP,
    5. Brocke B,
    6. Kirschbaum C
    (2012) Children under stress: COMT genotype and stressful life events predict cortisol increase in an acute social stress paradigm. Int J Neuropsychopharmacol 15:1229–1239, doi:10.1017/S1461145711001763, pmid:22152146.
    OpenUrlAbstract/FREE Full Text
    1. Arnone D,
    2. McKie S,
    3. Elliott R,
    4. Juhasz G,
    5. Thomas EJ,
    6. Downey D,
    7. Williams S,
    8. Deakin JF,
    9. Anderson IM
    (2012) State-dependent changes in hippocampal grey matter in depression. Mol Psychiatry 18:1265–1272, doi:10.1038/mp.2012.150, pmid:23128153.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Bilder RM,
    2. Volavka J,
    3. Lachman HM,
    4. Grace AA
    (2004) The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29:1943–1961, doi:10.1038/sj.npp.1300542, pmid:15305167.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Boeijinga PH,
    2. Boddeke HW
    (1996) Activation of 5-HT1B receptors suppresses low but not high frequency synaptic transmission in the rat subicular cortex in vitro. Brain Res 721:59–65, doi:10.1016/0006-8993(96)00149-7, pmid:8793084.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Brown ES,
    2. Woolston DJ,
    3. Frol A,
    4. Bobadilla L,
    5. Khan DA,
    6. Hanczyc M,
    7. Rush AJ,
    8. Fleckenstein J,
    9. Babcock E,
    10. Cullum CM
    (2004) Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry 55:538–545, doi:10.1016/j.biopsych.2003.09.010, pmid:15023583.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Cai X,
    2. Kallarackal AJ,
    3. Kvarta MD,
    4. Goluskin S,
    5. Gaylor K,
    6. Bailey AM,
    7. Lee HK,
    8. Huganir RL,
    9. Thompson SM
    (2013) Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression. Nat Neurosci 16:464–472, doi:10.1038/nn.3355, pmid:23502536.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Canli T,
    2. Qiu M,
    3. Omura K,
    4. Congdon E,
    5. Haas BW,
    6. Amin Z,
    7. Herrmann MJ,
    8. Constable RT,
    9. Lesch KP
    (2006) Neural correlates of epigenesis. Proc Natl Acad Sci U S A 103:16033–16038, doi:10.1073/pnas.0601674103, pmid:17032778.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Caspi A,
    2. Moffitt TE
    (2006) Gene–environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 7:583–590, doi:10.1038/nrn1925, pmid:16791147.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Caspi A,
    2. Moffitt TE,
    3. Thornton A,
    4. Freedman D,
    5. Amell JW,
    6. Harrington H,
    7. Smeijers J,
    8. Silva PA
    (1996) The life history calendar: a research and clinical assessment method for collecting retrospective event-history data. Int J Method Psych 6:101–114, doi:10.1002/(SICI)1234-988X(199607)6:2<101::AID-MPR156>3.3.CO%3B2-E.
    OpenUrlCrossRef
  11. ↵
    1. Caspi A,
    2. Sugden K,
    3. Moffitt TE,
    4. Taylor A,
    5. Craig IW,
    6. Harrington H,
    7. McClay J,
    8. Mill J,
    9. Martin J,
    10. Braithwaite A,
    11. Poulton R
    (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386–389, doi:10.1126/science.1083968, pmid:12869766.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Chen DY,
    2. Bambah-Mukku D,
    3. Pollonini G,
    4. Alberini CM
    (2012) Glucocorticoid receptors recruit the CaMKIIalpha-BDNF-CREB pathways to mediate memory consolidation. Nat Neurosci 15:1707–1714, doi:10.1038/nn.3266, pmid:23160045.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Cloninger CR,
    2. Svrakic DM,
    3. Przybeck TR
    (1993) A psychobiological model of temperament and character. Arch Gen Psychiatry 50:975–990, doi:10.1001/archpsyc.1993.01820240059008, pmid:8250684.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Cole J,
    2. Weinberger DR,
    3. Mattay VS,
    4. Cheng X,
    5. Toga AW,
    6. Thompson PM,
    7. Powell-Smith G,
    8. Cohen-Woods S,
    9. Simmons A,
    10. McGuffin P,
    11. Fu CH
    (2011) No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression. Genes Brain Behav 10:756–764, doi:10.1111/j.1601-183X.2011.00714.x, pmid:21692988.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Czéh B,
    2. Lucassen PJ
    (2007) What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated? Eur Arch Psychiatry Clin Neurosci 257:250–260, doi:10.1007/s00406-007-0728-0, pmid:17401728.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Dannlowski U,
    2. Stuhrmann A,
    3. Beutelmann V,
    4. Zwanzger P,
    5. Lenzen T,
    6. Grotegerd D,
    7. Domschke K,
    8. Hohoff C,
    9. Ohrmann P,
    10. Bauer J,
    11. Lindner C,
    12. Postert C,
    13. Konrad C,
    14. Arolt V,
    15. Heindel W,
    16. Suslow T,
    17. Kugel H
    (2012) Limbic scars: long-term consequences of childhood maltreatment revealed by functional and structural magnetic resonance imaging. Biol Psychiatry 71:286–293, doi:10.1016/j.biopsych.2011.10.021, pmid:22112927.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Davidson RJ,
    2. McEwen BS
    (2012) Social influences on neuroplasticity: stress and interventions to promote well-being. Nat Neurosci 15:689–695, doi:10.1038/nn.3093, pmid:22534579.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Delgado y Palacios R,
    2. Campo A,
    3. Henningsen K,
    4. Verhoye M,
    5. Poot D,
    6. Dijkstra J,
    7. Van Audekerke J,
    8. Benveniste H,
    9. Sijbers J,
    10. Wiborg O,
    11. Van der Linden A
    (2011) Magnetic resonance imaging and spectroscopy reveal differential hippocampal changes in anhedonic and resilient subtypes of the chronic mild stress rat model. Biol Psychiatry 70:449–457, doi:10.1016/j.biopsych.2011.05.014, pmid:21762877.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Domschke K,
    2. Baune BT,
    3. Havlik L,
    4. Stuhrmann A,
    5. Suslow T,
    6. Kugel H,
    7. Zwanzger P,
    8. Grotegerd D,
    9. Sehlmeyer C,
    10. Arolt V,
    11. Dannlowski U
    (2012) Catechol-O-methyltransferase gene variation: impact on amygdala response to aversive stimuli. Neuroimage 60:2222–2229, doi:10.1016/j.neuroimage.2012.02.039, pmid:22387174.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Drabant EM,
    2. Hariri AR,
    3. Meyer-Lindenberg A,
    4. Munoz KE,
    5. Mattay VS,
    6. Kolachana BS,
    7. Egan MF,
    8. Weinberger DR
    (2006) Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch Gen Psychiatry 63:1396–1406, doi:10.1001/archpsyc.63.12.1396, pmid:17146014.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Dutt A,
    2. McDonald C,
    3. Dempster E,
    4. Prata D,
    5. Shaikh M,
    6. Williams I,
    7. Schulze K,
    8. Marshall N,
    9. Walshe M,
    10. Allin M,
    11. Collier D,
    12. Murray R,
    13. Bramon E
    (2009) The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis. Psychol Med 39:1783–1797, doi:10.1017/S0033291709990316, pmid:19573260.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Erickson KI,
    2. Voss MW,
    3. Prakash RS,
    4. Basak C,
    5. Szabo A,
    6. Chaddock L,
    7. Kim JS,
    8. Heo S,
    9. Alves H,
    10. White SM,
    11. Wojcicki TR,
    12. Mailey E,
    13. Vieira VJ,
    14. Martin SA,
    15. Pence BD,
    16. Woods JA,
    17. McAuley E,
    18. Kramer AF
    (2011) Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A 108:3017–3022, doi:10.1073/pnas.1015950108, pmid:21282661.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Fischl B,
    2. Salat DH,
    3. Busa E,
    4. Albert M,
    5. Dieterich M,
    6. Haselgrove C,
    7. van der Kouwe A,
    8. Killiany R,
    9. Kennedy D,
    10. Klaveness S,
    11. Montillo A,
    12. Makris N,
    13. Rosen B,
    14. Dale AM
    (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341–355, doi:10.1016/S0896-6273(02)00569-X, pmid:11832223.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Fisher PM,
    2. Holst KK,
    3. McMahon B,
    4. Haahr ME,
    5. Madsen K,
    6. Gillings N,
    7. Baaré WF,
    8. Jensen PS,
    9. Knudsen GM
    (2012) 5-HTTLPR status predictive of neocortical 5-HT4 binding assessed with [(11)C]SB207145 PET in humans. Neuroimage 62:130–136, doi:10.1016/j.neuroimage.2012.05.013, pmid:22584237.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Freund J,
    2. Brandmaier AM,
    3. Lewejohann L,
    4. Kirste I,
    5. Kritzler M,
    6. Krüger A,
    7. Sachser N,
    8. Lindenberger U,
    9. Kempermann G
    (2013) Emergence of individuality in genetically identical mice. Science 340:756–759, doi:10.1126/science.1235294, pmid:23661762.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Frodl T,
    2. Koutsouleris N,
    3. Bottlender R,
    4. Born C,
    5. Jäger M,
    6. Mörgenthaler M,
    7. Scheuerecker J,
    8. Zill P,
    9. Baghai T,
    10. Schüle C,
    11. Rupprecht R,
    12. Bondy B,
    13. Reiser M,
    14. Möller HJ,
    15. Meisenzahl EM
    (2008) Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Mol Psychiatry 13:1093–1101, doi:10.1038/mp.2008.62, pmid:19008895.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Frodl T,
    2. Reinhold E,
    3. Koutsouleris N,
    4. Donohoe G,
    5. Bondy B,
    6. Reiser M,
    7. Möller HJ,
    8. Meisenzahl EM
    (2010) Childhood stress, serotonin transporter gene and brain structures in major depression. Neuropsychopharmacology 35:1383–1390, doi:10.1038/npp.2010.8, pmid:20147891.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Frustaci A,
    2. Pozzi G,
    3. Gianfagna F,
    4. Manzoli L,
    5. Boccia S
    (2008) Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits. Neuropsychobiology 58:163–170, doi:10.1159/000182892, pmid:19088493.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Garthe A,
    2. Behr J,
    3. Kempermann G
    (2009) Adult-generated hippocampal neurons allow the flexible use of spatially precise learning strategies. PLoS One 4:e5464, doi:10.1371/journal.pone.0005464, pmid:19421325.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Gaspar P,
    2. Cases O,
    3. Maroteaux L
    (2003) The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 4:1002–1012, doi:10.1038/nrn1256, pmid:14618156.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Gatt JM,
    2. Nemeroff CB,
    3. Dobson-Stone C,
    4. Paul RH,
    5. Bryant RA,
    6. Schofield PR,
    7. Gordon E,
    8. Kemp AH,
    9. Williams LM
    (2009) Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry 14:681–695, doi:10.1038/mp.2008.143, pmid:19153574.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Gianaros PJ,
    2. Jennings JR,
    3. Sheu LK,
    4. Greer PJ,
    5. Kuller LH,
    6. Matthews KA
    (2007) Prospective reports of chronic life stress predict decreased grey matter volume in the hippocampus. Neuroimage 35:795–803, doi:10.1016/j.neuroimage.2006.10.045, pmid:17275340.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Goldman D,
    2. Oroszi G,
    3. Ducci F
    (2005) The genetics of addictions: uncovering the genes. Nat Rev Genet 6:521–532, doi:10.1038/nrg1635, pmid:15995696.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Gray JD,
    2. Rubin TG,
    3. Hunter RG,
    4. McEwen BS
    (2013) Hippocampal gene expression changes underlying stress sensitization and recovery. Mol Psychiatry doi:10.1038/mp.2013.175, doi:10.1038/mp.2013.175, pmid:24342991, Advance online publication. Retrieved Dec. 17, 2013.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Hall H,
    2. Lundkvist C,
    3. Halldin C,
    4. Farde L,
    5. Pike VW,
    6. McCarron JA,
    7. Fletcher A,
    8. Cliffe IA,
    9. Barf T,
    10. Wikström H,
    11. Sedvall G
    (1997) Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Res 745:96–108, doi:10.1016/S0006-8993(96)01131-6, pmid:9037397.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Hariri AR,
    2. Mattay VS,
    3. Tessitore A,
    4. Kolachana B,
    5. Fera F,
    6. Goldman D,
    7. Egan MF,
    8. Weinberger DR
    (2002) Serotonin transporter genetic variation and the response of the human amygdala. Science 297:400–403, doi:10.1126/science.1071829, pmid:12130784.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. Hemani G,
    2. Shakhbazov K,
    3. Westra HJ,
    4. Esko T,
    5. Henders AK,
    6. McRae AF,
    7. Yang J,
    8. Gibson G,
    9. Martin NG,
    10. Metspalu A,
    11. Franke L,
    12. Montgomery GW,
    13. Visscher PM,
    14. Powell JE
    (2014) Detection and replication of epistasis influencing transcription in humans. Nature 508:249–253, doi:10.1038/nature13005, pmid:24572353.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Hernaus D,
    2. Collip D,
    3. Lataster J,
    4. Ceccarini J,
    5. Kenis G,
    6. Booij L,
    7. Pruessner J,
    8. Van Laere K,
    9. van Winkel R,
    10. van Os J,
    11. Myin-Germeys I
    (2013) COMT Val158Met genotype selectively alters prefrontal [18F]fallypride displacement and subjective feelings of stress in response to a psychosocial stress challenge. PLoS One 8:e65662, doi:10.1371/journal.pone.0065662, pmid:23799032.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Hill WG,
    2. Goddard ME,
    3. Visscher PM
    (2008) Data and theory point to mainly additive genetic variance for complex traits. PLoS Genet 4:e1000008, doi:10.1371/journal.pgen.1000008, pmid:18454194.
    OpenUrlCrossRefPubMed
  40. ↵
    1. Holm S
    (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6:65–70.
    OpenUrl
  41. ↵
    1. Honea R,
    2. Verchinski BA,
    3. Pezawas L,
    4. Kolachana BS,
    5. Callicott JH,
    6. Mattay VS,
    7. Weinberger DR,
    8. Meyer-Lindenberg A
    (2009) Impact of interacting functional variants in COMT on regional gray matter volume in human brain. Neuroimage 45:44–51, doi:10.1016/j.neuroimage.2008.10.064, pmid:19071221.
    OpenUrlCrossRefPubMed
  42. ↵
    1. Howe ML
    (2013) Memory development: implications for adults recalling childhood experiences in the courtroom. Nat Rev Neurosci 14:869–876, doi:10.1038/nrn3627, pmid:24169901.
    OpenUrlCrossRefPubMed
  43. ↵
    1. Hu XZ,
    2. Lipsky RH,
    3. Zhu G,
    4. Akhtar LA,
    5. Taubman J,
    6. Greenberg BD,
    7. Xu K,
    8. Arnold PD,
    9. Richter MA,
    10. Kennedy JL,
    11. Murphy DL,
    12. Goldman D
    (2006) Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78:815–826, doi:10.1086/503850, pmid:16642437.
    OpenUrlCrossRefPubMed
  44. ↵
    1. Jeanneteau F,
    2. Garabedian MJ,
    3. Chao MV
    (2008) Activation of Trk neurotrophin receptors by glucocorticoids provides a neuroprotective effect. Proc Natl Acad Sci U S A 105:4862–4867, doi:10.1073/pnas.0709102105, pmid:18347336.
    OpenUrlAbstract/FREE Full Text
  45. ↵
    1. Jiang R,
    2. Brummett BH,
    3. Babyak MA,
    4. Siegler IC,
    5. Williams RB
    (2013) Brain-derived neurotrophic factor (BDNF) Val66Met and adulthood chronic stress interact to affect depressive symptoms. J Psychiatr Res 47:233–239, doi:10.1016/j.jpsychires.2012.10.009, pmid:23140671.
    OpenUrlCrossRefPubMed
  46. ↵
    1. Kambeitz JP,
    2. Bhattacharyya S,
    3. Kambeitz-Ilankovic LM,
    4. Valli I,
    5. Collier DA,
    6. McGuire P
    (2012) Effect of BDNF val(66)met polymorphism on declarative memory and its neural substrate: a meta-analysis. Neurosci Biobehav Rev 36:2165–2177, doi:10.1016/j.neubiorev.2012.07.002, pmid:22813992.
    OpenUrlCrossRefPubMed
  47. ↵
    1. Karst H,
    2. Joëls M
    (2003) Effect of chronic stress on synaptic currents in rat hippocampal dentate gyrus neurons. J Neurophysiol 89:625–633, doi:10.1152/jn.00691.2002, pmid:12522207.
    OpenUrlAbstract/FREE Full Text
  48. ↵
    1. Keller MC
    (2014) Gene × environment interaction studies have not properly controlled for potential confounders: the problem and the (simple) solution. Biol Psychiatry 75:18–24, doi:10.1016/j.biopsych.2013.09.006, pmid:24135711.
    OpenUrlCrossRefPubMed
  49. ↵
    1. Kempermann G,
    2. Kühn HG,
    3. Gage FH
    (1997) More hippocampal neurons in adult mice living in an enriched environment. Nature 386:493–495, doi:10.1038/386493a0, pmid:9087407.
    OpenUrlCrossRefPubMed
  50. ↵
    1. Klempin F,
    2. Beis D,
    3. Mosienko V,
    4. Kempermann G,
    5. Bader M,
    6. Alenina N
    (2013) Serotonin is required for exercise-induced adult hippocampal neurogenesis. J Neurosci 33:8270–8275, doi:10.1523/JNEUROSCI.5855-12.2013, pmid:23658167.
    OpenUrlAbstract/FREE Full Text
  51. ↵
    1. Krishnan V,
    2. Han MH,
    3. Graham DL,
    4. Berton O,
    5. Renthal W,
    6. Russo SJ,
    7. Laplant Q,
    8. Graham A,
    9. Lutter M,
    10. Lagace DC,
    11. Ghose S,
    12. Reister R,
    13. Tannous P,
    14. Green TA,
    15. Neve RL,
    16. Chakravarty S,
    17. Kumar A,
    18. Eisch AJ,
    19. Self DW,
    20. Lee FS,
    21. et al.
    (2007) Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131:391–404, doi:10.1016/j.cell.2007.09.018, pmid:17956738.
    OpenUrlCrossRefPubMed
  52. ↵
    1. Kühn S,
    2. Gallinat J
    (2013) Gray matter correlates of posttraumatic stress disorder: a quantitative meta-analysis. Biol Psychiatry 73:70–74, doi:10.1016/j.biopsych.2012.06.029, pmid:22840760.
    OpenUrlCrossRefPubMed
  53. ↵
    1. Laatikainen LM,
    2. Sharp T,
    3. Bannerman DM,
    4. Harrison PJ,
    5. Tunbridge EM
    (2012) Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibition. J Psychopharmacol 26:1561–1568, doi:10.1177/0269881112454228, pmid:22815336.
    OpenUrlAbstract/FREE Full Text
  54. ↵
    1. Lisman J,
    2. Grace AA,
    3. Duzel E
    (2011) A neoHebbian framework for episodic memory: role of dopamine-dependent late LTP. Trends Neurosci 34:536–547, doi:10.1016/j.tins.2011.07.006, pmid:21851992.
    OpenUrlCrossRefPubMed
  55. ↵
    1. Luby JL,
    2. Barch DM,
    3. Belden A,
    4. Gaffrey MS,
    5. Tillman R,
    6. Babb C,
    7. Nishino T,
    8. Suzuki H,
    9. Botteron KN
    (2012) Maternal support in early childhood predicts larger hippocampal volumes at school age. Proc Natl Acad Sci U S A 109:2854–2859, doi:10.1073/pnas.1118003109, pmid:22308421.
    OpenUrlAbstract/FREE Full Text
  56. ↵
    1. Lyons DM,
    2. Buckmaster PS,
    3. Lee AG,
    4. Wu C,
    5. Mitra R,
    6. Duffey LM,
    7. Buckmaster CL,
    8. Her S,
    9. Patel PD,
    10. Schatzberg AF
    (2010) Stress coping stimulates hippocampal neurogenesis in adult monkeys. Proc Natl Acad Sci U S A 107:14823–14827, doi:10.1073/pnas.0914568107, pmid:20675584.
    OpenUrlAbstract/FREE Full Text
  57. ↵
    1. MacDougall MJ,
    2. Howland JG
    (2013) Acute stress, but not corticosterone, disrupts short- and long-term synaptic plasticity in rat dorsal subiculum via glucocorticoid receptor activation. Cereb Cortex 23:2611–2619, doi:10.1093/cercor/bhs247, pmid:22918985.
    OpenUrlAbstract/FREE Full Text
  58. ↵
    1. MacQueen G,
    2. Frodl T
    (2011) The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? Mol Psychiatry 16:252–264, doi:10.1038/mp.2010.80, pmid:20661246.
    OpenUrlCrossRefPubMed
  59. ↵
    1. Mandelli L,
    2. Serretti A
    (2013) Gene environment interaction studies in depression and suicidal behavior: an update. Neurosci Biobehav Rev 37:2375–2397, doi:10.1016/j.neubiorev.2013.07.011, pmid:23886513.
    OpenUrlCrossRefPubMed
  60. ↵
    1. Martinowich K,
    2. Lu B
    (2008) Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33:73–83, doi:10.1038/sj.npp.1301571, pmid:17882234.
    OpenUrlCrossRefPubMed
  61. ↵
    1. Matsumoto M,
    2. Weickert CS,
    3. Akil M,
    4. Lipska BK,
    5. Hyde TM,
    6. Herman MM,
    7. Kleinman JE,
    8. Weinberger DR
    (2003) Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience 116:127–137, doi:10.1016/S0306-4522(02)00556-0, pmid:12535946.
    OpenUrlCrossRefPubMed
  62. ↵
    1. McEwen BS
    (2001) Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann N Y Acad Sci 933:265–277, doi:10.1111/j.1749-6632.2001.tb05830.x, pmid:12000027.
    OpenUrlCrossRefPubMed
  63. ↵
    1. McEwen BS,
    2. Eiland L,
    3. Hunter RG,
    4. Miller MM
    (2012) Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology 62:3–12, doi:10.1016/j.neuropharm.2011.07.014, pmid:21807003.
    OpenUrlCrossRefPubMed
  64. ↵
    1. Mier D,
    2. Kirsch P,
    3. Meyer-Lindenberg A
    (2010) Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol Psychiatry 15:918–927, doi:10.1038/mp.2009.36, pmid:19417742.
    OpenUrlCrossRefPubMed
  65. ↵
    1. Migliarini S,
    2. Pacini G,
    3. Pelosi B,
    4. Lunardi G,
    5. Pasqualetti M
    (2013) Lack of brain serotonin affects postnatal development and serotonergic neuronal circuitry formation. Mol Psychiatry 18:1106–1118, doi:10.1038/mp.2012.128, pmid:23007167.
    OpenUrlCrossRefPubMed
  66. ↵
    1. Miller R,
    2. Wankerl M,
    3. Stalder T,
    4. Kirschbaum C,
    5. Alexander N
    (2013) The serotonin transporter gene-linked polymorphic region (5-HTTLPR) and cortisol stress reactivity: a meta-analysis. Mol Psychiatry 18:1018–1024, doi:10.1038/mp.2012.124, pmid:22945032.
    OpenUrlCrossRefPubMed
  67. ↵
    1. Moffitt TE,
    2. Caspi A,
    3. Rutter M
    (2005) Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry 62:473–481, doi:10.1001/archpsyc.62.5.473, pmid:15867100.
    OpenUrlCrossRefPubMed
  68. ↵
    1. Molendijk ML,
    2. Bus BA,
    3. Spinhoven P,
    4. Kaimatzoglou A,
    5. Oude Voshaar RC,
    6. Penninx BW,
    7. van IJzendoorn MH,
    8. Elzinga BM
    (2012) A systematic review and meta-analysis on the association between BDNF val(66)met and hippocampal volume: a genuine effect or a winners curse? Am J Med Genetics 159B:731–740, doi:10.1002/ajmg.b.32078, pmid:22815222.
    OpenUrlCrossRefPubMed
  69. ↵
    1. Nelson MD,
    2. Saykin AJ,
    3. Flashman LA,
    4. Riordan HJ
    (1998) Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 55:433–440, doi:10.1001/archpsyc.55.5.433, pmid:9596046.
    OpenUrlCrossRefPubMed
  70. ↵
    1. Niitsu T,
    2. Fabbri C,
    3. Bentini F,
    4. Serretti A
    (2013) Pharmacogenetics in major depression: a comprehensive meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 45:183–194, doi:10.1016/j.pnpbp.2013.05.011, pmid:23733030.
    OpenUrlCrossRefPubMed
  71. ↵
    1. Parihar VK,
    2. Hattiangady B,
    3. Kuruba R,
    4. Shuai B,
    5. Shetty AK
    (2011) Predictable chronic mild stress improves mood, hippocampal neurogenesis and memory. Mol Psychiatry 16:171–183, doi:10.1038/mp.2009.130, pmid:20010892.
    OpenUrlCrossRefPubMed
  72. ↵
    1. Petrik D,
    2. Lagace DC,
    3. Eisch AJ
    (2012) The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building? Neuropharmacology 62:21–34, doi:10.1016/j.neuropharm.2011.09.003, pmid:21945290.
    OpenUrlCrossRefPubMed
  73. ↵
    1. Pezawas L,
    2. Verchinski BA,
    3. Mattay VS,
    4. Callicott JH,
    5. Kolachana BS,
    6. Straub RE,
    7. Egan MF,
    8. Meyer-Lindenberg A,
    9. Weinberger DR
    (2004) The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24:10099–10102, doi:10.1523/JNEUROSCI.2680-04.2004, pmid:15537879.
    OpenUrlAbstract/FREE Full Text
  74. ↵
    1. Pilger A,
    2. Haslacher H,
    3. Ponocny-Seliger E,
    4. Perkmann T,
    5. Böhm K,
    6. Budinsky A,
    7. Girard A,
    8. Klien K,
    9. Jordakieva G,
    10. Pezawas L,
    11. Wagner O,
    12. Godnic-Cvar J,
    13. Winker R
    (2014) Affective and inflammatory responses among orchestra musicians in performance situation. Brain Behav Immun 37:23–29, doi:10.1016/j.bbi.2013.10.018, pmid:24513877.
    OpenUrlCrossRefPubMed
  75. ↵
    1. Pollak DD,
    2. Monje FJ,
    3. Zuckerman L,
    4. Denny CA,
    5. Drew MR,
    6. Kandel ER
    (2008) An animal model of a behavioral intervention for depression. Neuron 60:149–161, doi:10.1016/j.neuron.2008.07.041, pmid:18940595.
    OpenUrlCrossRefPubMed
  76. ↵
    1. Ruiz-Sanz JI,
    2. Aurrekoetxea I,
    3. Ruiz del Agua A,
    4. Ruiz-Larrea MB
    (2007) Detection of catechol-O-methyltransferase Val158Met polymorphism by a simple one-step tetra-primer amplification refractory mutation system-PCR. Mol Cell Probes 21:202–207, doi:10.1016/j.mcp.2006.12.001, pmid:17337160.
    OpenUrlCrossRefPubMed
  77. ↵
    1. Sahay A,
    2. Scobie KN,
    3. Hill AS,
    4. O'Carroll CM,
    5. Kheirbek MA,
    6. Burghardt NS,
    7. Fenton AA,
    8. Dranovsky A,
    9. Hen R
    (2011) Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature 472:466–470, doi:10.1038/nature09817, pmid:21460835.
    OpenUrlCrossRefPubMed
  78. ↵
    1. Sanfilipo MP,
    2. Benedict RH,
    3. Zivadinov R,
    4. Bakshi R
    (2004) Correction for intracranial volume in analysis of whole brain atrophy in multiple sclerosis: the proportion vs residual method. Neuroimage 22:1732–1743, doi:10.1016/j.neuroimage.2004.03.037, pmid:15275929.
    OpenUrlCrossRefPubMed
  79. ↵
    1. Sapolsky RM,
    2. Uno H,
    3. Rebert CS,
    4. Finch CE
    (1990) Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 10:2897–2902, pmid:2398367.
    OpenUrlAbstract
  80. ↵
    1. Schloesser RJ,
    2. Lehmann M,
    3. Martinowich K,
    4. Manji HK,
    5. Herkenham M
    (2010) Environmental enrichment requires adult neurogenesis to facilitate the recovery from psychosocial stress. Mol Psychiatry 15:1152–1163, doi:10.1038/mp.2010.34, pmid:20308988.
    OpenUrlCrossRefPubMed
  81. ↵
    1. Smolka MN,
    2. Schumann G,
    3. Wrase J,
    4. Grüsser SM,
    5. Flor H,
    6. Mann K,
    7. Braus DF,
    8. Goldman D,
    9. Büchel C,
    10. Heinz A
    (2005) Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci 25:836–842, doi:10.1523/JNEUROSCI.1792-04.2005, pmid:15673663.
    OpenUrlAbstract/FREE Full Text
  82. ↵
    1. Smolka MN,
    2. Bühler M,
    3. Schumann G,
    4. Klein S,
    5. Hu XZ,
    6. Moayer M,
    7. Zimmer A,
    8. Wrase J,
    9. Flor H,
    10. Mann K,
    11. Braus DF,
    12. Goldman D,
    13. Heinz A
    (2007) Gene-gene effects on central processing of aversive stimuli. Mol Psychiatry 12:307–317, doi:10.1038/sj.mp.4001946, pmid:17211439.
    OpenUrlCrossRefPubMed
  83. ↵
    1. Snyder JS,
    2. Soumier A,
    3. Brewer M,
    4. Pickel J,
    5. Cameron HA
    (2011) Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 476:458–461, doi:10.1038/nature10287, pmid:21814201.
    OpenUrlCrossRefPubMed
  84. ↵
    1. Sousa N,
    2. Lukoyanov NV,
    3. Madeira MD,
    4. Almeida OF,
    5. Paula-Barbosa MM
    (2000) Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience 97:253–266, doi:10.1016/S0306-4522(00)00050-6, pmid:10799757.
    OpenUrlCrossRefPubMed
  85. ↵
    1. Spalding KL,
    2. Bergmann O,
    3. Alkass K,
    4. Bernard S,
    5. Salehpour M,
    6. Huttner HB,
    7. Boström E,
    8. Westerlund I,
    9. Vial C,
    10. Buchholz BA,
    11. Possnert G,
    12. Mash DC,
    13. Druid H,
    14. Frisén J
    (2013) Dynamics of hippocampal neurogenesis in adult humans. Cell 153:1219–1227, doi:10.1016/j.cell.2013.05.002, pmid:23746839.
    OpenUrlCrossRefPubMed
  86. ↵
    1. Stone LB,
    2. McGeary JE,
    3. Palmer RH,
    4. Gibb BE
    (2013) Identifying genetic predictors of depression risk: 5-HTTLPR and BDNF Val66Met polymorphisms are associated with rumination and co-rumination in adolescents. Front Genet 4:246, doi:10.3389/fgene.2013.00246, pmid:24312122.
    OpenUrlCrossRefPubMed
  87. ↵
    1. Taliaz D,
    2. Stall N,
    3. Dar DE,
    4. Zangen A
    (2010) Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. Mol Psychiatry 15:80–92, doi:10.1038/mp.2009.67, pmid:19621014.
    OpenUrlCrossRefPubMed
  88. ↵
    1. Teicher MH,
    2. Anderson CM,
    3. Polcari A
    (2012) Childhood maltreatment is associated with reduced volume in the hippocampal subfields CA3, dentate gyrus, and subiculum. Proc Natl Acad Sci U S A 109:E563–E572, doi:10.1073/pnas.1115396109, pmid:22331913.
    OpenUrlAbstract/FREE Full Text
  89. ↵
    1. Uher R,
    2. McGuffin P
    (2008) The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol Psychiatry 13:131–146, doi:10.1038/sj.mp.4002067, pmid:17700575.
    OpenUrlCrossRefPubMed
  90. ↵
    1. Van Leemput K,
    2. Bakkour A,
    3. Benner T,
    4. Wiggins G,
    5. Wald LL,
    6. Augustinack J,
    7. Dickerson BC,
    8. Golland P,
    9. Fischl B
    (2009) Automated segmentation of hippocampal subfields from ultra-high resolution in vivo MRI. Hippocampus 19:549–557, doi:10.1002/hipo.20615, pmid:19405131.
    OpenUrlCrossRefPubMed
  91. ↵
    1. Wendland JR,
    2. Martin BJ,
    3. Kruse MR,
    4. Lesch KP,
    5. Murphy DL
    (2006) Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry 11:224–226, doi:10.1038/sj.mp.4001789, pmid:16402131.
    OpenUrlCrossRefPubMed
  92. ↵
    1. Yang J,
    2. Benyamin B,
    3. McEvoy BP,
    4. Gordon S,
    5. Henders AK,
    6. Nyholt DR,
    7. Madden PA,
    8. Heath AC,
    9. Martin NG,
    10. Montgomery GW,
    11. Goddard ME,
    12. Visscher PM
    (2010) Common SNPs explain a large proportion of the heritability for human height. Nat Genet 42:565–569, doi:10.1038/ng.608, pmid:20562875.
    OpenUrlCrossRefPubMed
  93. ↵
    1. Yu H,
    2. Wang DD,
    3. Wang Y,
    4. Liu T,
    5. Lee FS,
    6. Chen ZY
    (2012) Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants. J Neurosci 32:4092–4101, doi:10.1523/JNEUROSCI.5048-11.2012, pmid:22442074.
    OpenUrlAbstract/FREE Full Text
  94. ↵
    1. Zubieta JK,
    2. Heitzeg MM,
    3. Smith YR,
    4. Bueller JA,
    5. Xu K,
    6. Xu Y,
    7. Koeppe RA,
    8. Stohler CS,
    9. Goldman D
    (2003) COMT val158met genotype affects μ-opioid neurotransmitter responses to a pain stressor. Science 299:1240–1243, doi:10.1126/science.1078546, pmid:12595695.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

The Journal of Neuroscience: 34 (30)
Journal of Neuroscience
Vol. 34, Issue 30
23 Jul 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Additive Gene–Environment Effects on Hippocampal Structure in Healthy Humans
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Additive Gene–Environment Effects on Hippocampal Structure in Healthy Humans
Ulrich Rabl, Bernhard M. Meyer, Kersten Diers, Lucie Bartova, Andreas Berger, Dominik Mandorfer, Ana Popovic, Christian Scharinger, Julia Huemer, Klaudius Kalcher, Gerald Pail, Helmuth Haslacher, Thomas Perkmann, Christian Windischberger, Burkhard Brocke, Harald H. Sitte, Daniela D. Pollak, Jean-Claude Dreher, Siegfried Kasper, Nicole Praschak-Rieder, Ewald Moser, Harald Esterbauer, Lukas Pezawas
Journal of Neuroscience 23 July 2014, 34 (30) 9917-9926; DOI: 10.1523/JNEUROSCI.3113-13.2014

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Additive Gene–Environment Effects on Hippocampal Structure in Healthy Humans
Ulrich Rabl, Bernhard M. Meyer, Kersten Diers, Lucie Bartova, Andreas Berger, Dominik Mandorfer, Ana Popovic, Christian Scharinger, Julia Huemer, Klaudius Kalcher, Gerald Pail, Helmuth Haslacher, Thomas Perkmann, Christian Windischberger, Burkhard Brocke, Harald H. Sitte, Daniela D. Pollak, Jean-Claude Dreher, Siegfried Kasper, Nicole Praschak-Rieder, Ewald Moser, Harald Esterbauer, Lukas Pezawas
Journal of Neuroscience 23 July 2014, 34 (30) 9917-9926; DOI: 10.1523/JNEUROSCI.3113-13.2014
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • COMT
  • SLC6A4
  • BDNF
  • MRI
  • hippocampus
  • stress

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Articles

  • Choice Behavior Guided by Learned, But Not Innate, Taste Aversion Recruits the Orbitofrontal Cortex
  • Maturation of Spontaneous Firing Properties after Hearing Onset in Rat Auditory Nerve Fibers: Spontaneous Rates, Refractoriness, and Interfiber Correlations
  • Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration
Show more Articles

Neurobiology of Disease

  • Choice Behavior Guided by Learned, But Not Innate, Taste Aversion Recruits the Orbitofrontal Cortex
  • Maturation of Spontaneous Firing Properties after Hearing Onset in Rat Auditory Nerve Fibers: Spontaneous Rates, Refractoriness, and Interfiber Correlations
  • Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration
Show more Neurobiology of Disease
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2022 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.